AIM ImmunoTech Inc. has announced that it has received a warning notification from NYSE American LLC, indicating noncompliance with the minimum stockholders' equity requirements outlined in Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide. As of March 31, 2025, AIM reported a stockholders' deficit of negative $3.9 million, alongside losses in its five most recent fiscal years. The company has until June 11, 2026, to regain compliance, following a previously accepted plan by NYSE American. The letter does not affect AIM's business operations or its trading, which continues under the symbol "AIM" on the NYSE American.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。